M. Wharton, R. Strikas, R. Harpaz, L. Rotz, and B. Schwartz, Recommendations for using smallpox vaccine in a pre-event vaccination program, Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC), pp.1-16, 2003.

S. Patterson, T. Papagatsias, and A. Benlahrech, Use of Adenovirus in Vaccines for HIV, Handb Exp Pharmacol, pp.275-293, 2009.
DOI : 10.1007/978-3-540-71029-5_13

C. Harro, M. Robertson, M. Lally, O. Neill, L. Edupuganti et al., Vaccines in Healthy Adults, AIDS Research and Human Retroviruses, vol.25, issue.1, pp.103-114, 2009.
DOI : 10.1089/aid.2008.0212

A. White, Why vaccines are not the answer ??? The failure of V520 and the importance of cell-mediated immunity in the fight against HIV, Medical Hypotheses, vol.71, issue.6, pp.909-913, 2008.
DOI : 10.1016/j.mehy.2008.07.027

P. Doherty, S. Hou, and R. Tripp, CD8+ T-cell memory to viruses, Current Opinion in Immunology, vol.6, issue.4, pp.545-552, 1994.
DOI : 10.1016/0952-7915(94)90139-2

S. Kaech, E. Wherry, and R. Ahmed, VACCINES: EFFECTOR AND MEMORY T-CELL DIFFERENTIATION: IMPLICATIONS FOR VACCINE DEVELOPMENT, Nature Reviews Immunology, vol.166, issue.4, pp.251-262, 2002.
DOI : 10.1046/j.1365-2249.2001.01600.x

H. Robinson, T cells versus HIV-1: fighting exhaustion as well as escape, Nature Immunology, vol.4, issue.1, pp.12-13, 2003.
DOI : 10.1038/ni0103-12

J. Post, S. Ratnarajah, and A. Lloyd, Immunological determinants of the outcomes from primary hepatitis C infection, Cellular and Molecular Life Sciences, vol.66, issue.5, pp.733-756, 2009.
DOI : 10.1007/s00018-008-8270-4

L. Brown and A. Kelso, Prospects for an influenza vaccine that induces crossprotective cytotoxic T lymphocytes, Immunol Cell Biol, 2009.

R. Seder, P. Darrah, and M. Roederer, T-cell quality in memory and protection: implications for vaccine design, Nature Reviews Immunology, vol.27, issue.4, pp.247-258, 2008.
DOI : 10.1038/nri2274

J. Miller, R. Van-der-most, R. Akondy, J. Glidewell, and S. Albott, Human Effector and Memory CD8+ T Cell Responses to??Smallpox and Yellow Fever Vaccines, Immunity, vol.28, issue.5, pp.710-722, 2008.
DOI : 10.1016/j.immuni.2008.02.020

D. Godelaine, J. Carrasco, S. Lucas, V. Karanikas, and B. Schuler-thurner, Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide, The Journal of Immunology, vol.171, issue.9, pp.4893-4897, 2003.
DOI : 10.4049/jimmunol.171.9.4893

A. Boon, G. De-mutsert, R. Fouchier, A. Osterhaus, and G. Rimmelzwaan, Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity, Clinical and Experimental Immunology, vol.172, issue.1, pp.45-52, 2005.
DOI : 10.1006/cimm.1996.0245

A. Boon, G. De-mutsert, D. Van-baarle, D. Smith, and A. Lapedes, Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes, The Journal of Immunology, vol.172, issue.4, pp.2453-2460, 2004.
DOI : 10.4049/jimmunol.172.4.2453

C. Germeau, W. Ma, F. Schiavetti, C. Lurquin, and E. Henry, High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens, The Journal of Experimental Medicine, vol.58, issue.2, pp.241-248, 2005.
DOI : 10.1126/science.1076514

L. Lau, B. Jamieson, T. Somasundaram, and R. Ahmed, Cytotoxic T-cell memory without antigen, Nature, vol.369, issue.6482, pp.648-652, 1994.
DOI : 10.1038/369648a0

E. Hammarlund, M. Lewis, S. Hansen, L. Strelow, and J. Nelson, Duration of antiviral immunity after smallpox vaccination, Nature Medicine, vol.9, issue.9, 2003.
DOI : 10.1038/nm917

B. Combadiere, A. Boissonnas, G. Carcelain, E. Lefranc, and A. Samri, Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-?????producing T Cell Memory to Smallpox in Humans, The Journal of Experimental Medicine, vol.512, issue.11, pp.1585-1593, 2004.
DOI : 10.1126/science.277.5322.112

W. Demkowicz, . Jr, R. Littaua, J. Wang, and F. Ennis, Human cytotoxic Tcell memory: long-lived responses to vaccinia virus, J Virol, vol.70, pp.2627-2631, 1996.

J. Banchereau and A. Palucka, Dendritic cells as therapeutic vaccines against cancer, Nature Reviews Immunology, vol.10, issue.4, pp.296-306, 2005.
DOI : 10.1007/s00262-003-0429-0

J. Banchereau and R. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998.
DOI : 10.1038/32588

T. Kupper and R. Fuhlbrigge, Immune surveillance in the skin: mechanisms and clinical consequences, Nature Reviews Immunology, vol.101, issue.3, pp.211-222, 2004.
DOI : 10.1038/nri1310

E. Klechevsky, R. Morita, M. Liu, Y. Cao, and S. Coquery, Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells, Immunity, vol.29, issue.3, pp.497-510, 2008.
DOI : 10.1016/j.immuni.2008.07.013

B. Combadiere and B. Mahe, Particle-based vaccines for transcutaneous vaccination, Comparative Immunology, Microbiology and Infectious Diseases, vol.31, issue.2-3, pp.293-315, 2008.
DOI : 10.1016/j.cimid.2007.07.015

I. Belyakov, S. Hammond, J. Ahlers, G. Glenn, and J. Berzofsky, Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells, Journal of Clinical Investigation, vol.113, issue.7, pp.998-1007, 2004.
DOI : 10.1172/JCI20261

J. Berzofsky, J. Ahlers, and I. Belyakov, STRATEGIES FOR DESIGNING AND OPTIMIZING NEW GENERATION VACCINES, Nature Reviews Immunology, vol.163, issue.3, pp.209-219, 2001.
DOI : 10.1084/jem.193.2.233

L. Borgne, M. Etchart, N. Goubier, A. Lira, S. Sirard et al., Dendritic Cells Rapidly Recruited into Epithelial Tissues via CCR6/CCL20 Are Responsible for CD8+ T Cell Crosspriming In Vivo, Immunity, vol.24, issue.2, pp.191-201, 2006.
DOI : 10.1016/j.immuni.2006.01.005

URL : https://hal.archives-ouvertes.fr/inserm-00000041

J. Bos and M. Kapsenberg, The skin immune system: progress in cutaneous biology, Immunology Today, vol.14, issue.2, pp.75-78, 1993.
DOI : 10.1016/0167-5699(93)90062-P

G. Glenn, M. Rao, G. Matyas, and C. Alving, Skin immunization made possible by cholera toxin, Nature, vol.391, issue.6670, p.851, 1998.
DOI : 10.1038/36014

G. Glenn, T. Scharton-kersten, R. Vassell, C. Mallett, and T. Hale, Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge, J Immunol, vol.161, pp.3211-3214, 1998.

G. Glenn, D. Taylor, X. Li, S. Frankel, and A. Montemarano, Transcutaneous Immunization, Nat Med, vol.6, pp.1403-1406, 2000.
DOI : 10.1385/1-59259-083-7:315

S. Hammond, D. Walwender, C. Alving, and G. Glenn, Transcutaneous immunization: T cell responses and boosting of existing immunity, Vaccine, vol.19, issue.17-19, pp.2701-2707, 2001.
DOI : 10.1016/S0264-410X(00)00506-5

G. Matyas, A. Friedlander, G. Glenn, S. Little, and J. Yu, Needle-Free Skin Patch Vaccination Method for Anthrax, Infection and Immunity, vol.72, issue.2, pp.1181-1183, 2004.
DOI : 10.1128/IAI.72.2.1181-1183.2004

G. Glenn, D. Flyer, L. Ellingsworth, S. Frech, and D. Frerichs, Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch, Expert Review of Vaccines, vol.6, issue.5, pp.809-819, 2007.
DOI : 10.1586/14760584.6.5.809

D. Frerichs, L. Ellingsworth, S. Frech, D. Flyer, and C. Villar, Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch, Vaccine, vol.26, issue.22, pp.2782-2787, 2008.
DOI : 10.1016/j.vaccine.2008.02.070

A. Vogt, B. Combadiere, S. Hadam, K. Stieler, and J. Lademann, 40nm, but not 750 or 1,500nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin, Journal of Investigative Dermatology, vol.126, issue.6, pp.1316-1322, 2006.
DOI : 10.1038/sj.jid.5700226

A. Vogt, B. Mahe, D. Costagliola, O. Bonduelle, and S. Hadam, Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans, The Journal of Immunology, vol.180, issue.3, pp.1482-1489, 2008.
DOI : 10.4049/jimmunol.180.3.1482

A. Vogt, N. Mandt, J. Lademann, H. Schaefer, and U. Blume-peytavi, Follicular Targeting???A Promising Tool in Selective Dermatotherapy, Journal of Investigative Dermatology Symposium Proceedings, vol.10, issue.3, pp.252-255, 2005.
DOI : 10.1111/j.1087-0024.2005.10124.x

P. Doherty, S. Turner, R. Webby, and P. Thomas, Influenza and the challenge for immunology, Nature Immunology, vol.165, issue.5, pp.449-455, 2006.
DOI : 10.1038/ni1343

J. Greenbaum, M. Kotturi, Y. Kim, C. Oseroff, and K. Vaughan, Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population, Proceedings of the National Academy of Sciences, vol.106, issue.48, pp.20365-20370, 2009.
DOI : 10.1073/pnas.0911580106

J. Kohlmeier and D. Woodland, Immunity to Respiratory Viruses, Annual Review of Immunology, vol.27, issue.1, pp.61-82, 2009.
DOI : 10.1146/annurev.immunol.021908.132625

A. Cerwenka, T. Morgan, and R. Dutton, Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial, J Immunol, vol.163, pp.5535-5543, 1999.

J. Kohlmeier, L. Rumsey, M. Chan, and S. Benedict, The outcome of T-cell costimulation through intercellular adhesion molecule-1 differs from costimulation through leucocyte function-associated antigen-1, Immunology, vol.161, issue.2, pp.152-157, 2003.
DOI : 10.1126/science.1064571

B. Walker and D. Burton, Toward an AIDS Vaccine, Science, vol.320, issue.5877, pp.760-764, 2008.
DOI : 10.1126/science.1152622

P. Goulder and D. Watkins, Impact of MHC class I diversity on immune control of immunodeficiency virus replication, Nature Reviews Immunology, vol.80, issue.8, pp.619-630, 2008.
DOI : 10.1038/nri2357

D. Watkins, D. Burton, E. Kallas, J. Moore, and W. Koff, Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans, Nature Medicine, vol.21, issue.6, pp.617-621, 2008.
DOI : 10.1038/nm.f.1759

S. Hansen, C. Vieville, N. Whizin, L. Coyne-johnson, and D. Siess, Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge, Nature Medicine, vol.72, issue.3, pp.293-299, 2009.
DOI : 10.1097/00002030-199801000-00001

B. Mahe, A. Vogt, C. Liard, D. Duffy, and V. Abadie, Nanoparticle-Based Targeting of Vaccine Compounds to Skin Antigen-Presenting Cells By Hair Follicles and their Transport in Mice, Journal of Investigative Dermatology, vol.129, issue.5, 2008.
DOI : 10.1038/jid.2008.356

B. Pulendran, J. Smith, G. Caspary, K. Brasel, and D. Pettit, Distinct dendritic cell subsets differentially regulate the class of immune response in vivo, Proceedings of the National Academy of Sciences, vol.96, issue.3, pp.1036-1041, 1999.
DOI : 10.1073/pnas.96.3.1036

D. Dudziak, A. Kamphorst, G. Heidkamp, V. Buchholz, and C. Trumpfheller, Differential Antigen Processing by Dendritic Cell Subsets in Vivo, Science, vol.315, issue.5808, pp.107-111, 2007.
DOI : 10.1126/science.1136080

P. Stoitzner, C. Tripp, P. Douillard, S. Saeland, and N. Romani, Migratory Langerhans Cells in Mouse Lymph Nodes in Steady State and Inflammation, Journal of Investigative Dermatology, vol.125, issue.1, pp.116-125, 2005.
DOI : 10.1111/j.0022-202X.2005.23757.x

P. Stoitzner, C. Tripp, A. Eberhart, K. Price, and J. Jung, Langerhans cells cross-present antigen derived from skin, Proceedings of the National Academy of Sciences, vol.103, issue.20, pp.7783-7788, 2006.
DOI : 10.1073/pnas.0509307103

A. Kissenpfennig and B. Malissen, Langerhans cells ??? revisiting the paradigm using genetically engineered mice, Trends in Immunology, vol.27, issue.3, pp.132-139, 2006.
DOI : 10.1016/j.it.2006.01.003

URL : https://hal.archives-ouvertes.fr/hal-00080584

M. Matsuo, Y. Nagata, E. Sato, D. Atanackovic, and D. Valmori, IFN-?? enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation, Proceedings of the National Academy of Sciences, vol.101, issue.40, pp.14467-14472, 2004.
DOI : 10.1073/pnas.0405947101

G. Ratzinger, J. Baggers, M. De-cos, J. Yuan, and T. Dao, Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells, The Journal of Immunology, vol.173, issue.4, pp.2780-2791, 2004.
DOI : 10.4049/jimmunol.173.4.2780

I. Belyakov, J. Ahlers, and J. Berzofsky, Mucosal AIDS vaccines: current status and future directions, Expert Review of Vaccines, vol.3, issue.sup1, pp.65-73, 2004.
DOI : 10.1586/14760584.3.4.S65

N. Otberg, H. Richter, H. Schaefer, U. Blume-peytavi, and W. Sterry, Variations of Hair Follicle Size and Distribution in Different Body Sites, Journal of Investigative Dermatology, vol.122, issue.1, pp.14-19, 2004.
DOI : 10.1046/j.0022-202X.2003.22110.x

S. Mangelsdorf, N. Otberg, H. Maibach, R. Sinkgraven, and W. Sterry, Ethnic Variation in Vellus Hair Follicle Size and Distribution, Skin Pharmacology and Physiology, vol.19, issue.3, pp.159-167, 2006.
DOI : 10.1159/000093050

N. Etchart, A. Hennino, M. Friede, K. Dahel, and M. Dupouy, Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans, Vaccine, vol.25, issue.39-40, pp.6891-6899, 2007.
DOI : 10.1016/j.vaccine.2007.07.014

H. Yagi, H. Hashizume, T. Horibe, Y. Yoshinari, and M. Hata, Induction of Therapeutically Relevant Cytotoxic T Lymphocytes in Humans by Percutaneous Peptide Immunization, Cancer Research, vol.66, issue.20, pp.10136-10144, 2006.
DOI : 10.1158/0008-5472.CAN-06-1029

P. Doherty, D. Topham, R. Tripp, R. Cardin, and J. Brooks, Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections, Immunological Reviews, vol.155, issue.1, pp.105-117, 1997.
DOI : 10.1016/0952-7915(93)90026-O

S. Hou, L. Hyland, K. Ryan, A. Portner, and P. Doherty, Virus-specific CD8+ T-cell memory determined by clonal burst size, Nature, vol.369, issue.6482, pp.652-654, 1994.
DOI : 10.1038/369652a0

J. Haanen, M. Wolkers, A. Kruisbeek, and T. Schumacher, Memory T Cells by Viral Variants, The Journal of Experimental Medicine, vol.152, issue.9, pp.1319-1328, 1999.
DOI : 10.1084/jem.188.9.1705

S. Watabe, K. Xin, A. Ihata, L. Liu, and A. Honsho, Protection against influenza virus challenge by topical application of influenza DNA vaccine, Vaccine, vol.19, issue.31, pp.4434-4444, 2001.
DOI : 10.1016/S0264-410X(01)00194-3

M. Graham and T. Braciale, Resistance to and Recovery from Lethal Influenza Virus Infection in B Lymphocyte???deficient Mice, The Journal of Experimental Medicine, vol.155, issue.12, pp.2063-2068, 1997.
DOI : 10.1084/jem.183.5.2153

S. Epstein, C. Lo, J. Misplon, and J. Bennink, Mechanism of protective immunity against influenza virus infection in mice without antibodies, J Immunol, vol.160, pp.322-327, 1998.

P. Pala, A. Townsend, and B. Askonas, Viral recognition by influenza A virus cross-reactive cytotoxic T (Tc) cells: The proportion of Tc cells that recognize nucleoprotein varies between individual mice, European Journal of Immunology, vol.35, issue.2, pp.193-198, 1986.
DOI : 10.1002/eji.1830160215

A. Townsend, J. Rothbard, F. Gotch, G. Bahadur, and D. Wraith, The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides, Cell, vol.44, issue.6, pp.959-968, 1986.
DOI : 10.1016/0092-8674(86)90019-X

G. Belz and P. Doherty, Virus-Specific and Bystander CD8+ T-Cell Proliferation in the Acute and Persistent Phases of a Gammaherpesvirus Infection, Journal of Virology, vol.75, issue.9, pp.4435-4438, 2001.
DOI : 10.1128/JVI.75.9.4435-4438.2001

G. Belz, W. Xie, and P. Doherty, Diversity of Epitope and Cytokine Profiles for Primary and Secondary Influenza A Virus-Specific CD8+ T Cell Responses, The Journal of Immunology, vol.166, issue.7, pp.4627-4633, 2001.
DOI : 10.4049/jimmunol.166.7.4627

G. Belz, W. Xie, J. Altman, and P. Doherty, A Previously Unrecognized H-2Db-Restricted Peptide Prominent in the Primary Influenza A Virus-Specific CD8+ T-Cell Response Is Much Less Apparent following Secondary Challenge, Journal of Virology, vol.74, issue.8, pp.3486-3493, 2000.
DOI : 10.1128/JVI.74.8.3486-3493.2000

M. Tamura, K. Kuwano, I. Kurane, and F. Ennis, Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1- specific, H2-specific, and H1-and H2-cross-reactive murine cytotoxic Tlymphocyte clones, J Virol, vol.72, pp.9404-9406, 1998.

K. Kuwano, M. Tamura, and F. Ennis, Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone, Virology, vol.178, issue.1, pp.174-179, 1990.
DOI : 10.1016/0042-6822(90)90391-4

K. Kuwano, M. Scott, J. Young, and F. Ennis, Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes, Journal of Experimental Medicine, vol.169, issue.4, pp.1361-1371, 1989.
DOI : 10.1084/jem.169.4.1361

K. Kuwano, T. Braciale, and F. Ennis, Cytotoxic T Lymphocytes Recognize a Cross-Reactive Epitope on the Transmembrane Region of Influenza H1 and H2 Hemagglutinins, Viral Immunology, vol.2, issue.3, pp.163-173, 1989.
DOI : 10.1089/vim.1989.2.163

K. Kuwano, M. Scott, J. Young, and F. Ennis, HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response, J Immunol, vol.140, pp.1264-1268, 1988.

D. Murasko, E. Bernstein, E. Gardner, P. Gross, and G. Munk, Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly, Experimental Gerontology, vol.37, issue.2-3, pp.427-439, 2002.
DOI : 10.1016/S0531-5565(01)00210-8

E. Bernstein, D. Kaye, E. Abrutyn, P. Gross, and M. Dorfman, Immune response to influenza vaccination in a large healthy elderly population, Vaccine, vol.17, issue.1, pp.82-94, 1999.
DOI : 10.1016/S0264-410X(98)00117-0

G. Makedonas and M. Betts, Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection, Springer Seminars in Immunopathology, vol.102, issue.12, pp.209-219, 2006.
DOI : 10.1007/s00281-006-0025-4

A. Harari, V. Dutoit, C. Cellerai, P. Bart, D. Pasquier et al., Functional signatures of protective antiviral T-cell immunity in human virus infections, Immunological Reviews, vol.17, issue.1, pp.236-254, 2006.
DOI : 10.1146/annurev.med.54.101601.152349

H. Fan, Q. Lin, G. Morrissey, and P. Khavari, Immunization via hair follicles by topical application of naked DNA to normal skin, Nat Biotechnol, vol.17, pp.870-872, 1999.

J. Lademann, N. Otberg, U. Jacobi, R. Hoffman, and U. Blume-peytavi, Follicular Penetration and Targeting, Journal of Investigative Dermatology Symposium Proceedings, vol.10, issue.3, pp.301-303, 2005.
DOI : 10.1111/j.1087-0024.2005.10121.x

URL : http://doi.org/10.1111/j.1087-0024.2005.10121.x

J. Lademann, H. Richter, U. Schaefer, U. Blume-peytavi, and A. Teichmann, Hair Follicles ??? A Long-Term Reservoir for Drug Delivery, Skin Pharmacology and Physiology, vol.19, issue.4, pp.232-236, 2006.
DOI : 10.1159/000093119

S. Naito, J. Maeyama, T. Mizukami, M. Takahashi, and I. Hamaguchi, Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant, Vaccine, vol.25, issue.52, pp.8762-8770, 2007.
DOI : 10.1016/j.vaccine.2007.10.031

G. Glenn and R. Kenney, Mass Vaccination: Solutions in the Skin, Curr Top Microbiol Immunol, vol.304, pp.247-268, 2006.
DOI : 10.1007/3-540-36583-4_14

R. Kenney, S. Frech, L. Muenz, C. Villar, and G. Glenn, Dose Sparing with Intradermal Injection of Influenza Vaccine, New England Journal of Medicine, vol.351, issue.22, pp.2295-2301, 2004.
DOI : 10.1056/NEJMoa043540

S. Halperin, B. Smith, K. Clarke, J. Treanor, and T. Mabrouk, A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults, Human Vaccines, vol.1, issue.1, pp.37-42, 2005.
DOI : 10.4161/hv.1.1.1553

R. Draenert, M. Altfeld, C. Brander, N. Basgoz, and C. Corcoran, Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses, Journal of Immunological Methods, vol.275, issue.1-2, pp.19-29, 2003.
DOI : 10.1016/S0022-1759(02)00541-0

A. Beavis and R. Kalejta, Simultaneous Analysis of the Cyan, Green, and Yellow Fluorescent Proteins, Curr Protoc Cytom Chapter, vol.369, p.16, 2001.
DOI : 10.1002/0471142956.cy0116s16

V. Appay and R. Sl, The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining, Journal of Immunological Methods, vol.268, issue.1, pp.9-19, 2002.
DOI : 10.1016/S0022-1759(02)00195-3

V. Appay, D. Nixon, S. Donahoe, G. Gillespie, and T. Dong, T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function, The Journal of Experimental Medicine, vol.139, issue.1, pp.63-75, 2000.
DOI : 10.1086/314868